Qingdao Vland Biotech Inc.
SHH: 603739.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Gang Chen
- Employees
- 1,571
- Headquarters
- Qingdao, China
- IPO year
- 2019
- Market cap
- CN¥3.8B
- Website
- https://www.vlandgroup.com
Loading 603739…
Loading profile data…Frequently asked questions about 603739
What does Qingdao Vland Biotech Inc. (603739.SS) do?
Qingdao Vland Biotech INC. engages in the research and development of enzymes, probiotics, and animal vaccines and health products. It offers animal feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, and animal and plant probiotics. The company also offers animal vaccines and biological products,...
Where does 603739.SS trade?
Qingdao Vland Biotech Inc. (603739.SS) trades on the Shanghai Stock Exchange.
What sector is 603739.SS in?
Qingdao Vland Biotech Inc. (603739.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Qingdao Vland Biotech Inc.?
Gang Chen is the chief executive officer of Qingdao Vland Biotech Inc. (603739.SS).
Where is Qingdao Vland Biotech Inc. headquartered?
Qingdao Vland Biotech Inc. is headquartered in China.
Does 603739.SS pay a dividend?
Yes — Qingdao Vland Biotech Inc. (603739.SS) paid a trailing twelve-month dividend of CNY 0.10 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 603739.SS go public?
Qingdao Vland Biotech Inc. (603739.SS) completed its initial public offering in 2019.